Utvalda publikationer (Grönlunds forskargrupp)
Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial.
Neimert-Andersson T, Binnmyr J, Enoksson M, Langebäck J, Zettergren L, Hällgren A, et al, Vaccine 2014 Oct;32(45):5967-74
Designing a multimer allergen for diagnosis and immunotherapy of dog allergic patients.
Nilsson O, Neimert-Andersson T, Bronge M, Grundström J, Sarma R, Uchtenhagen H, et al, PLoS ONE 2014 ;9(10):e111041
Dog saliva - an important source of dog allergens.
Polovic N, Wadén K, Binnmyr J, Hamsten C, Grönneberg R, Palmberg C, et al
Allergy 2013 ;68(5):585-92
Characterization of the dog lipocalin allergen Can f 6: the role in cross-reactivity with cat and horse.
Nilsson O, Binnmyr J, Zoltowska A, Saarne T, van Hage M, Grönlund H
Allergy 2012 Jun;67(6):751-7
Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy.
Neimert-Andersson T, Thunberg S, Swedin L, Wiedermann U, Jacobsson-Ekman G, Dahlén S, et al
Allergy 2008 May;63(5):518-26
The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family.
Kaiser L, Grönlund H, Sandalova T, Ljunggren H, van Hage-Hamsten M, Achour A, et al
J. Biol. Chem. 2003 Sep;278(39):37730-5
The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT).
Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Grönlund H
Clin. Exp. Allergy 1999 Jul;29(7):896-904